Search Results for “” – Page 9 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Model

118 Publications found

The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.

b

AIDS (London, England)

September 24, 2017

p HIV POCT

c Economics Model
The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC.

b

Annals of oncology : official journal of the European Society for Medical Oncology

September 1, 2017

p Cancer

c Economics Highlighted Model
Budget impact analysis of sFlt-1/PlGF ratio as prediction test in Italian women with suspected preeclampsia.

b

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

September 1, 2017

p Preeclampsia

c Economics Model
Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing.

b

Lung cancer (Amsterdam, Netherlands)

May 1, 2017

p Cancer

c Economics Model
Extensive testing or focused testing of patients with elevated liver enzymes.

b

Journal of hepatology

February 1, 2017

p Liver Disease

c Economics Highlighted Model
Neonatal Screening: Cost-utility Analysis for Galactosemia.

b

Iranian journal of public health

January 1, 2017

p Newborn Screening

c Economics Model
Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study.

b

The lancet. HIV

December 1, 2016

p HIV POCT

c Economics Model
sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK.

b

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

December 1, 2016

p Preeclampsia

c Economics Model
Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.

b

JAMA pediatrics

December 1, 2016

p Newborn Screening

c Economics Model
A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing.

b

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

November 1, 2016

p Cancer

c Economics Model